Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.

Tumor cell migration is a key process for cancer cell dissemination and metastasis that is controlled by signal-mediated cytoskeletal and cell matrix adhesion remodeling. Using a phagokinetic track assay with migratory H1299 cells, we performed an siRNA screen of almost 1,500 genes encoding kinases/phosphatases and adhesome- and migration-related proteins to identify genes that affect tumor cell migration speed and persistence. Thirty candidate genes that altered cell migration were validated in live tumor cell migration assays. Eight were associated with metastasis-free survival in breast cancer patients, with integrin β3-binding protein (ITGB3BP), MAP3K8, NIMA-related kinase (NEK2), and SHC-transforming protein 1 (SHC1) being the most predictive. Examination of genes that modulate migration indicated that SRPK1, encoding the splicing factor kinase SRSF protein kinase 1, is relevant to breast cancer outcomes, as it was highly expressed in basal breast cancer. Furthermore, high SRPK1 expression correlated with poor breast cancer disease outcome and preferential metastasis to the lungs and brain. In 2 independent murine models of breast tumor metastasis, stable shRNA-based SRPK1 knockdown suppressed metastasis to distant organs, including lung, liver, and spleen, and inhibited focal adhesion reorganization. Our study provides comprehensive information on the molecular determinants of tumor cell migration and suggests that SRPK1 has potential as a drug target for limiting breast cancer metastasis.

[1]  J. Foekens,et al.  Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment. , 2000, Journal of the National Cancer Institute.

[2]  T. Borodina,et al.  Transcriptome analysis by strand-specific sequencing of complementary DNA , 2009, Nucleic acids research.

[3]  W. Hahn,et al.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. , 2009, Molecular cell.

[4]  F. Verbeek,et al.  Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation , 2014, Oncogene.

[5]  J. Foekens,et al.  Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[7]  J. Ursini-Siegel,et al.  The ShcA adaptor protein is a critical regulator of breast cancer progression , 2008, Cell cycle.

[8]  M. Rajendran,et al.  p66Shc—a longevity redox protein in human prostate cancer progression and metastasis , 2010, Cancer and Metastasis Reviews.

[9]  R. Padgett.  New connections between splicing and human disease. , 2012, Trends in genetics : TIG.

[10]  E. Danen.  Integrins: regulators of tissue function and cancer progression. , 2005, Current pharmaceutical design.

[11]  Kenneth M. Yamada,et al.  Cell–matrix adhesion , 2007, Journal of cellular physiology.

[12]  B. Geiger,et al.  The integrin adhesome: from genes and proteins to human disease , 2014, Nature Reviews Molecular Cell Biology.

[13]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[14]  M. Greenberg,et al.  EphA Receptors Regulate Growth Cone Dynamics through the Novel Guanine Nucleotide Exchange Factor Ephexin , 2001, Cell.

[15]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[16]  D. Schlaepfer,et al.  Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.

[17]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[18]  M. Ahmadian,et al.  Mechanistic Insights into Specificity, Activity, and Regulatory Elements of the Regulator of G-protein Signaling (RGS)-containing Rho-specific Guanine Nucleotide Exchange Factors (GEFs) p115, PDZ-RhoGEF (PRG), and Leukemia-associated RhoGEF (LARG)* , 2011, The Journal of Biological Chemistry.

[19]  Benjamin Geiger,et al.  Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown , 2009, The Journal of cell biology.

[20]  A. Huttenlocher,et al.  Integrins in cell migration. , 2007, Methods in enzymology.

[21]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[22]  B. van de Water,et al.  Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. , 2005, Cancer research.

[23]  A. Ventura,et al.  Integrated Systems and Technologies: Mathematical Oncology P38g Promotes Breast Cancer Cell Motility and Metastasis through Regulation of Rhoc Gtpase, Cytoskeletal Architecture, and a Novel Leading Edge Behavior , 2022 .

[24]  G. Yoon,et al.  Translocational Inefficiency of Intracellular Proteins in Senescence of Human Diploid Fibroblasts , 2001, Annals of the New York Academy of Sciences.

[25]  Yi Zhang,et al.  Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer , 2007, BMC Cancer.

[26]  J. Foekens,et al.  Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. , 2000, Journal of the National Cancer Institute.

[27]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[28]  Larry Norton,et al.  Latent bone metastasis in breast cancer tied to Src-dependent survival signals. , 2009, Cancer cell.

[29]  J. Boonstra,et al.  Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A 431 cells , 2005 .

[30]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[31]  Sylvia E. Le Dévédec,et al.  Functional screening with a live cell imaging-based random cell migration assay. , 2011, Methods in molecular biology.

[32]  Benjamin Geiger,et al.  Molecular architecture and function of matrix adhesions. , 2011, Cold Spring Harbor perspectives in biology.

[33]  J. Mccormick,et al.  Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts , 2010, BMC Cancer.

[34]  N. Cheung,et al.  ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy , 2012, Front. Oncol..

[35]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[36]  Ming-chuan Zhao,et al.  Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition , 2011, Molecular and Cellular Biochemistry.

[37]  Anastasia Khvorova,et al.  Identification of genes that regulate epithelial cell migration using an siRNA screening approach , 2008, Nature Cell Biology.

[38]  Chung-Liang Ho,et al.  An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells. , 2010, Carcinogenesis.

[39]  J. Adams,et al.  Phosphorylation mechanism and structure of serine‐arginine protein kinases , 2011, The FEBS journal.

[40]  Hans Clevers,et al.  Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines , 2010, Breast Cancer Research and Treatment.

[41]  A. Shrestha,et al.  Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. , 2012, Endocrinology.

[42]  Benjamin Geiger,et al.  The switchable integrin adhesome , 2010, Journal of Cell Science.

[43]  Jeffrey Wyckoff,et al.  Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.

[44]  H. Lane,et al.  ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.

[45]  Gianluca Bontempi,et al.  Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes , 2008, Clinical Cancer Research.

[46]  E. Mallon,et al.  Breast cancer patients’ clinical outcome measures are associated with Src kinase family member expression , 2010, British Journal of Cancer.

[47]  Wolfgang Huber,et al.  Detecting differential usage of exons from RNA-Seq data , 2012 .

[48]  Benjamin Geiger,et al.  Identification of Novel Pro-Migratory, Cancer-Associated Genes Using Quantitative, Microscopy-Based Screening , 2008, PloS one.

[49]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[50]  M. Ladomery,et al.  WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. , 2011, Cancer cell.

[51]  S. Itzkovitz,et al.  Functional atlas of the integrin adhesome , 2007, Nature Cell Biology.

[52]  L. Miller,et al.  Colonic , and Pancreatic Carcinomas Mitogen-Activated Protein Kinase Pathways in Breast , Associated with Tumorigenic Imbalance in Serine-Arginine Protein Kinase 1 Overexpression Is , 2007 .

[53]  E. Turco,et al.  The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cells. , 2011, American journal of cancer research.

[54]  T. Michel,et al.  Angiotensin-II and MARCKS , 2012, The Journal of Biological Chemistry.